LUNG DISEASES, INTERSTITIAL

This study is testing a pill called H01 (hymecromone) in adults with progressive interstitial lung disease, a condition that causes severe, often fatal scarring of the lungs. Over 5 months, about 37 participants will take the drug for 12 weeks to see if it reduces a key marker of…

This early-stage study is testing whether a mist made from donated human amniotic fluid is safe and might help people with interstitial lung disease (ILD), a condition that causes progressive scarring of the lungs. The trial will enroll 50 adults with ILD to inhale the experiment…

This study is testing whether adding the drug belimumab to standard treatment can help control lung scarring (interstitial lung disease) in adults whose scarring is caused by an underlying autoimmune condition like lupus or rheumatoid arthritis. Researchers will measure if the dr…

This study is testing whether molecules collected from a person's cough can act as a 'liquid biopsy' to detect early signs of lung cancer and other lung diseases. Researchers will compare cough samples to samples taken during invasive bronchoscopy procedures to see if they provid…

This study creates a research registry by collecting past, current, and future medical records from patients treated at the Simmons Center for Interstitial Lung Disease. The goal is to gather information from up to 5,000 adults to help researchers learn more about these complex l…

This study aims to create a database and test a screening program to catch early signs of interstitial lung disease (ILD), a type of lung scarring, in people who have other health conditions that put them at risk. Researchers will compare new screening results with past patient d…